Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Daiichi Sankyo Company, Limited (4568.T) stock price, news, quote and history
4+ hour, 12+ min ago (378+ words) Yahoo Finance Singapore Daiichi Sankyo Company, Limited (4568.T) Daiichi Sankyo Company, Limited Overview Drug Manufacturers - General / Healthcare Daiichi Sankyo Company, Limited manufactures and sells pharmaceutical products in Japan and internationally. The company offers Enhertu for the treatment of HER2 positive and low…...
Massive Bio Partners with TOUCH, The Black Breast Cancer Alliance and Navigating Trials to Expand Cancer Patients' Access to Clinical Trials
1+ mon, 3+ week ago (203+ words) AI-powered trial matching now available through two trusted cancer advocacy and navigation platforms Through this partnership, patients visiting either platform will be able to submit their information and receive personalized clinical trial matches powered by Massive Bio's SYNERGY-AI platform. Navigating…...
Agendia to Present New FLEX Study Data at ASCO 2026 Supporting NCCN Clinical Practice Guidelines in Oncology Update Recognizing MammaPrint for Guiding Anthracycline Use in Early-Stage Breast Cancer
2+ mon, 4+ day ago (486+ words) Poster #46 | June 1, 1:30 p.m. – 4:30 p.m. CDT | Presenter: Steven Isakoff Association of the 70-gene assay and homologous recombination deficiency in patients with High Risk 2 breast cancers This real-world analysis of 1,298 patients from the FLEX study evaluated whether MP + BP classifications are associated with…...
Momcozy Debuts New Maternal Care Innovations at ABC Kids Expo 2026
2+ mon, 1+ week ago (285+ words) LAS VEGAS, May 14, 2026 /PRNewswire/ -- Momcozy, the global leader in wearable breast pumps and maternal care innovation, today announced the debut of several new maternal care offerings at ABC Kids Expo 2026, reinforcing the brand's continued commitment to developing technology designed around…...
Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint
3+ mon, 3+ week ago (241+ words) In addition to the neoadjuvant Phase III study (KN026-004) that has met its primary endpoint, the adjuvant Phase III study (KN026-007) completed first patient dosing in March 2026 and plans to enroll approximately 1,800 patients with high recurrence risk after surgery. Domestically developed bispecific…...
Emagine Solutions Technology Wins ACA Grant, Announces Open Application for Groundbreaking Arizona Maternal Health Study
4+ mon, 1+ day ago (198+ words) TUCSON, Ariz., March 24, 2026--(BUSINESS WIRE)--Emagine Solutions Technology today announced that the Arizona Commerce Authority (ACA) has awarded the maternal health innovator a coveted $250,000 grant through its WearTech Applied Research Center. Emagine is now seeking participants for its maternal health…...
Kisqali® Receives Positive Draft Recommendation From Canada's Drug Agency For All Eligible Early Breast Cancer Patients at High Risk of Recurrence
5+ mon, 2+ week ago (926+ words) The draft recommendation for Kisqali® (ribociclib tablets) from Canada's Drug Agency (CDA-AMC) supports public reimbursement for hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative stage II-III early breast cancer (eBC) in patients at high risk of recurrence.1 Breast…...